Clearline Capital’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,200
Closed -$293K 120
2025
Q2
$293K Sell
1,200
-1,043
-47% -$260K 0.01% 106
2025
Q1
$593K Sell
2,243
-2,102
-48% -$568K 0.04% 102
2024
Q4
$1.1M Buy
+4,345
New +$1.17M 0.15% 79
2024
Q2
Sell
-3,164
Closed -$1.1M 153
2024
Q1
$1.1M Buy
+3,164
New +$1.2M 0.05% 102
2023
Q3
Sell
-11,232
Closed -$5.02M 136
2023
Q2
$5.02M Buy
+11,232
New +$5.65M 0.29% 44

Other funds holding HUM

Clearline Capital's HUM Position: Q3 2025 in Review

Clearline Capital sold out of Humana (HUM) in Q3 2025, closing a stake of 1,200 shares — an estimated $293K sold.

Clearline Capital first reported a position in HUM in Q2 2023 and held it in 5 quarters. The position peaked at $5.02M in Q2 2023. 892 funds tracked by Wall St. Rank hold HUM as of Q3 2025.

  • Clearline Capital reported no remaining Humana position as of Q3 2025 after selling out during the quarter.
  • Clearline Capital sold 1,200 Humana shares in Q3 2025, an estimated $293K.
  • Clearline Capital first reported a position in Humana in Q2 2023 and held it in 5 quarters.
  • Clearline Capital's Humana position peaked at $5.02M in Q2 2023.
  • 892 funds tracked by Wall St. Rank held Humana as of Q3 2025.

Based on Clearline Capital's 13F filing for Q3 2025, filed 14 Nov 2025.